Matches in SemOpenAlex for { <https://semopenalex.org/work/W2399168289> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2399168289 abstract "Doxazosin, a selective alpha1-adrenoceptor antagonist, lowers blood pressure by reducing peripheral vascular resistance without causing reflex tachycardia. To discover whether antihypertensive treatment with an alpha1-adrenoceptor blocker is accompanied by an increase in sympathoadrenomedullary activity, we studied plasma catecholamine kinetics before and during treatment with doxazosin.Eleven patients with essential hypertension were studied before and after 3 months' treatment with doxazosin (4-8 mg a day). 3H-noradrenaline and 3H-adrenaline were infused simultaneously and blood samples were collected to calculate plasma catecholamine kinetics before and during sympatho-adrenomedullary stimulation (lower-body negative pressure).Doxazosin decreased systolic and diastolic blood pressure and forearm vascular resistance, whereas the heart rate did not change significantly. During doxazosin, baseline arterial plasma noradrenaline increased from 0.97 +/- 0.07 to 1.21 +/- 0.07 nmol/l, and this appeared to be due to an increase in total body noradrenaline spillover from 1.54 +/- 0.15 to 1.84 +/- 0.16 nmol/min; noradrenaline clearance did not change significantly. Forearm noradrenaline spillover also increased, from 0.89 +/- 0.18 to 1.48 +/- 0.23 pmol/100 ml per min. In contrast, arterial plasma adrenaline, total body adrenaline spillover and adrenaline clearance were not significantly affected by doxazosin treatment. The response of plasma noradrenaline and total body and forearm spillover of noradrenaline to lower-body negative pressure (-40 mmHg) was significantly increased during doxazosin administration, whereas the response of the adrenaline kinetic parameters were not altered.The blood pressure reduction induced by a chronic administration of the alpha1-adrenoceptor blocker doxazosin elicits a baroreceptor-mediated reflexive increase in sympathoneural but not in adrenomedullary activity. The latter finding might partly explain why the heart rate is not increased during chronic treatment with this alpha1-adrenoceptor blocking drug." @default.
- W2399168289 created "2016-06-24" @default.
- W2399168289 creator A5007794291 @default.
- W2399168289 creator A5029034113 @default.
- W2399168289 creator A5077249675 @default.
- W2399168289 creator A5082148145 @default.
- W2399168289 date "1995-12-01" @default.
- W2399168289 modified "2023-09-24" @default.
- W2399168289 title "Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension" @default.
- W2399168289 cites W1981871828 @default.
- W2399168289 cites W1993658009 @default.
- W2399168289 cites W2021201908 @default.
- W2399168289 cites W2068759643 @default.
- W2399168289 cites W2105746151 @default.
- W2399168289 cites W2137335941 @default.
- W2399168289 cites W2152836739 @default.
- W2399168289 cites W2408586216 @default.
- W2399168289 cites W64356322 @default.
- W2399168289 cites W65957098 @default.
- W2399168289 doi "https://doi.org/10.1097/00004872-199512010-00062" @default.
- W2399168289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8903663" @default.
- W2399168289 hasPublicationYear "1995" @default.
- W2399168289 type Work @default.
- W2399168289 sameAs 2399168289 @default.
- W2399168289 citedByCount "2" @default.
- W2399168289 crossrefType "journal-article" @default.
- W2399168289 hasAuthorship W2399168289A5007794291 @default.
- W2399168289 hasAuthorship W2399168289A5029034113 @default.
- W2399168289 hasAuthorship W2399168289A5077249675 @default.
- W2399168289 hasAuthorship W2399168289A5082148145 @default.
- W2399168289 hasBestOaLocation W23991682892 @default.
- W2399168289 hasConcept C126322002 @default.
- W2399168289 hasConcept C134018914 @default.
- W2399168289 hasConcept C158453852 @default.
- W2399168289 hasConcept C170493617 @default.
- W2399168289 hasConcept C2775859304 @default.
- W2399168289 hasConcept C2775894120 @default.
- W2399168289 hasConcept C2777097880 @default.
- W2399168289 hasConcept C2777590997 @default.
- W2399168289 hasConcept C2777953023 @default.
- W2399168289 hasConcept C71924100 @default.
- W2399168289 hasConcept C84393581 @default.
- W2399168289 hasConceptScore W2399168289C126322002 @default.
- W2399168289 hasConceptScore W2399168289C134018914 @default.
- W2399168289 hasConceptScore W2399168289C158453852 @default.
- W2399168289 hasConceptScore W2399168289C170493617 @default.
- W2399168289 hasConceptScore W2399168289C2775859304 @default.
- W2399168289 hasConceptScore W2399168289C2775894120 @default.
- W2399168289 hasConceptScore W2399168289C2777097880 @default.
- W2399168289 hasConceptScore W2399168289C2777590997 @default.
- W2399168289 hasConceptScore W2399168289C2777953023 @default.
- W2399168289 hasConceptScore W2399168289C71924100 @default.
- W2399168289 hasConceptScore W2399168289C84393581 @default.
- W2399168289 hasLocation W23991682891 @default.
- W2399168289 hasLocation W23991682892 @default.
- W2399168289 hasLocation W23991682893 @default.
- W2399168289 hasOpenAccess W2399168289 @default.
- W2399168289 hasPrimaryLocation W23991682891 @default.
- W2399168289 hasRelatedWork W1830365929 @default.
- W2399168289 hasRelatedWork W1990181720 @default.
- W2399168289 hasRelatedWork W2005437501 @default.
- W2399168289 hasRelatedWork W2016436947 @default.
- W2399168289 hasRelatedWork W2021550031 @default.
- W2399168289 hasRelatedWork W2051091528 @default.
- W2399168289 hasRelatedWork W2053581632 @default.
- W2399168289 hasRelatedWork W2128836566 @default.
- W2399168289 hasRelatedWork W2399168289 @default.
- W2399168289 hasRelatedWork W2411806376 @default.
- W2399168289 isParatext "false" @default.
- W2399168289 isRetracted "false" @default.
- W2399168289 magId "2399168289" @default.
- W2399168289 workType "article" @default.